Clinical and Applied Thrombosis/Hemostasis《临床与应用血栓/止血》(可网站投稿)

Clinical and Applied Thrombosis/Hemostasis《临床与应用血栓/止血》(年刊). Clinical and Applied Thrombosis/Hemostasis (CATH) is an open access, peer reviewed journal which is dedicated to serving as a forum for studies regarding the etiology, pathophysiology, clinical diagnosis, laboratory diagnosis, and treatment of thrombohemorrhagic disorders.

杂志简称:clin appl thromb、hem
中文译名:《临床与应用血栓/止血》
收录属性:scie(2024版), 目次收录(知网),英文期刊,
自引率:6.40%
投稿方向:医学、hematology血液学、peripheral vascular disease外周血管病

Clinical and Applied Thrombosis/Hemostasis《临床与应用血栓/止血》

SCI/E期刊基本信息

出版周期:年刊 地区:美国
中科院分区:4区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN 1076-0296;EISSN 1076-0296
杂志语言:英语
出版国家:美国

杂志官网 联系方式

出版地址:2455 TELLER RD,THOUSAND OAKS,USA,CA,91320
杂志邮箱:
投稿网址:https://mc.manuscriptcentral.com/cath
杂志官方网址:https://journals.sagepub.com/home/cat
出版商网址:http://www.sagepub.co.uk

杂志投稿要求

投稿须知【杂志社官方网站信息】

Clinical and Applied Thrombosis/Hemostasis

Manuscript Submission Guidelines:

This Journal is a member of the Committee on Publication Ethics.

This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Please read the guidelines below then visit the journal’s submission site https://mc.manuscriptcentral.com/cath to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

SAGE Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.

Only manuscripts of sufficient quality that meet the aims and scope of Clinical and Applied Thrombosis/Hemostasis will be reviewed.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal

Please note: Beginning January 1, 2022 the APC for CAT will be $2400 USD. This APC will apply to papers with original submission dates of Jan 1, 2022 onward.

Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:

1. Open Access

Clinical and Applied Thrombosis/Hemostasis is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.

For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.

2. Article processing charge (APC)

If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons licence.

Please note: Beginning January 1, 2022 the APC for CAT will be $2400 USD. This APC will apply to papers with original submission dates of Jan 1, 2022 onward.

3. What do we publish?

3.1 Aims & scope

Before submitting your manuscript to Clinical and Applied Thrombosis/Hemostasis, please ensure you have read the Aims & Scope.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/45475

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 下午12:14
下一篇 2024年11月9日 下午12:14

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

QQ:321628655
邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息